Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention

Abstract:
$11 Million in New Projects Approved in Atlanta

As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention

Atlanta, GA | Posted on May 19th, 2009

Meeting at the world's largest bioscience and biotechnology convention, the Kansas Bioscience Authority has approved more than $11 million in new investments as part of a $581 million initiative to help researchers and businesses thrive in the state.

The funding decisions made at the Bio International Convention will create bioscience centers of innovation in biomaterials and plant biology, expand cancer drug development efforts, and create a strong bioenergy research partnership between the University of Kansas and the Archer Daniels Midland Company.

The Kansas Innovation Center for Advanced Plant Design will receive $4 million over two years to develop advanced technologies for gene discovery, trait validation and crop improvement in order to deliver new products and production platforms. The global research team associated with the center will focus on emerging commercial opportunities for wheat and sorghum, crops in which Kansas has world- renowned leadership and expertise.

The center is a public and private collaboration of Kansas Wheat, Kansas State University, the University of Kansas, and many private investors. Within 10 years, the center is projected to create 36 patents, 20 commercial start-ups and 285 jobs.

The KBA also will invest $4 million in the Center of Innovation for Biomaterials in Orthopaedic Research to create medical instruments, medical devices, and composite implants that will improve the practice of orthopedic medicine. The center will focus on commercial viability, conducting research requested by industry to meet market needs and capitalizing on the concentration of composites expertise found in Wichita due to the state's longstanding aviation industry leadership.

Partnering to form this center are Wichita State University, the National Institute of Aviation Research, the Wichita Composites Advisory Board, Kansas State University, Pittsburg State University, and Via Christi Health. It is expected to increase employment in Kansas by 2,000 over 10 years.

This brings the number of approved centers of innovation to four after the March approval of the Kansas Bioscience Innovation Center in Drug Delivery and Kansas Bioenergy and Biorefining Center of Innovation.

Cancer drug development

* Adding to the investment of more than $32 million in drug discovery and delivery projects in March, the KBA is committing another $1.9 million this month:

* Lenexa-based CyDex Pharmaceuticals will receive $195,000 to commercialize re-formulated drugs that address limitations of existing therapies. A focus will be improving a cancer drug for patients with multiple myeloma (cancer of the Plasma B cells formed in the bone marrow).

* CritiTech and SCF Technologies of Lawrence were awarded $50,000 to further develop a novel approach to converting drugs into dry, sterile powder form. The process is expected to significantly reduce costs in drug manufacturing, while easing the process of administering drugs for both physicians and patients. The investment is a partial match to a $100,000 grant from the National Cancer Institute.

* Manhattan-based NanoScale will use $50,000 in KBA matching funds to expedite the testing of nanoparticles for diagnostic and therapeutic uses in fighting cancer. These "stealth" particles are expected to allow earlier disease detection and to improve the ability of drugs to hit their intended targets with fewer side effects. The company received a $150,000 Small Business Innovation Research award from the National Institutes of Health.

* A $500,000 Collaborative Cancer Research Initiative (CCRI) investment will go to the University of Kansas Cancer Center and Scripps Research Institute. The research is intended to reduce the unwanted toxicity often associated with chemotherapy and improve the treatment of breast and prostate cancers.

* A second $500,000 CCRI investment was approved to initiate Phase I clinical trials in the Wichita area through a partnership of the University of Kansas Cancer Center, Cancer Center of Kansas, Midwest Cancer Alliance and Via Christi Regional Medical Center. Phase I trials will complement the successful Phase II and III programs in Wichita and strengthen rural and regional treatment options.

* A $600,000 project budget was committed for the KBA to support the University of Kansas Cancer Center's efforts to bring cutting-edge cancer treatments closer to home for millions of Kansans through National Cancer Institute designation.

Bioenergy research partnership

The KBA will provide $1.2 million over three years for bioenergy research at the University of Kansas Center for Environmentally Beneficial Catalysis as a match to $1.2 million being invested by Archer Daniels Midland Company, which operates five processing plants, a technical center, and sales and distribution offices throughout Kansas. Research will focus on converting multiple feedstocks, including biomass, into a wide platform of fuels and chemicals to replace or improve upon petroleum-based products. The university will provide in-kind support valued at more than $334,000.

Approved investments are subject to final agreements between the KBA and investees.

####

About Kansas Bioscience Authority
The Kansas Bioscience Authority is a $581-million initiative created by the Kansas Economic Growth Act of 2004 to expand the state's world-class research capacity and bioscience clusters; support the growth of bioscience startups; and stimulate bioscience business expansion and attraction.

For more information, please click here

Contacts:
Kansas Bioscience Authority
25501 West Valley Parkway
Suite 100
Olathe, KS 66061
913-397-8300

Copyright © PRNewswire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014

Nanodiamonds Are Forever: A UCSB professorís research examines 13,000-year-old nanodiamonds from multiple locations across three continents August 27th, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Nanotech Security Corp. to Acquire Fortress Optical Features Ltd., a Leading Producer of Banknote Security Features August 27th, 2014

Investments/IPO's/Splits

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Harris & Harris Group Letter to Shareholders on Website August 19th, 2014

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014

Aspen Aerogels, Inc. to Present at Canaccord Genuity 34th Annual Growth Conference August 11th, 2014

Nanomedicine

PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014

The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment: Targeted therapy for hepatocellular carcinoma using nanotechnology August 27th, 2014

Introducing the multi-tasking nanoparticle: Versatile particles offer a wide variety of diagnostic and therapeutic applications August 26th, 2014

Symphony of nanoplasmonic and optical resonators leads to magnificent laser-like light emission August 26th, 2014

Announcements

Nanodiamonds Are Forever: A UCSB professorís research examines 13,000-year-old nanodiamonds from multiple locations across three continents August 27th, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Nanotech Security Corp. to Acquire Fortress Optical Features Ltd., a Leading Producer of Banknote Security Features August 27th, 2014

Malvern specialists to deliver inaugural short course on polymer characterization at Interplas 2014 August 27th, 2014

Nanobiotechnology

The channel that relaxes DNA: Relaxing DNA strands by using nano-channels: Instructions for use August 20th, 2014

Сalculations with Nanoscale Smart Particles August 19th, 2014

Interaction between Drug, DNA for Designing Anticancer Drugs Studied in Iran August 17th, 2014

Scientists fold RNA origami from a single strand: RNA origami is a new method for organizing molecules on the nanoscale. Using just a single strand of RNA, this technique can produce many complicated shapes. August 14th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE